CDMO Samsung Biologics Looks to Build on Success of San Francisco Facility With Potential U.S. Expansion
In 2020, Samsung Biologics, a leading contract development and manufacturing organization (CDMO), established a research and development facility in San Francisco, California. The facility, the CDMO’s first in the U.S., is equipped for high-quality cell line development and was built to bring Samsung Biologics’ contract development services (CDO) closer to clients. Now, as Samsung Biologics…